Stockreport

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights [Yahoo! Finance]

PMV Pharmaceuticals, Inc.  (PMVP) 
PDF patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 90% of sites activated across the U.S., Europe, U.K., and Asia-Pacific; interim analysis dat [Read more]